Significance of boost radiotherapy in early invasive ductal breast cancer with ductal carcinoma in situ component under negative surgical margins.

Shimizu, Naoko; Myojin, Miyako; Tamura, Motoshi; Nishiyama, Noriaki; Yamashiro, Katsushige; Yuyama, Yuichi; Okazaki, Yutaka; Suzuki, Yasuhiro; Takahashi, Masato

Shimizu, Naoko; Myojin, Miyako; Tamura, Motoshi; Nishiyama, Noriaki; Yamashiro, Katsushige; Yuyama, Yuichi; Okazaki, Yutaka; Suzuki, Yasuhiro; Takahashi, Masato.

J Radiat Res ; 63(1): 80-87, 2022 Jan 20.

Article in En | MEDLINE | ID: mdl-34718690

Subject(s)

Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Breast Neoplasms/radiotherapy; Breast Neoplasms/surgery; Carcinoma, Intraductal, Noninfiltrating/pathology; Carcinoma, Intraductal, Noninfiltrating/radiotherapy; Carcinoma, Intraductal, Noninfiltrating/surgery; Female; Humans; Margins of Excision; Mastectomy, Segmental/adverse effects; Middle Aged; Neoplasm Recurrence, Local/surgery

Key words

boost irradiation; ductal carcinoma in situ (DCIS) component; ipsilateral breast tumor recurrence (IBTR); negative margin; primary breast cancer

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Carcinoma, Intraductal, Noninfiltrating Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Journal: J Radiat Res Year: 2022 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google